BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Toussirot E. The Use of Janus Kinase Inhibitors in Axial Spondyloarthritis: Current Insights. Pharmaceuticals 2022;15:270. [DOI: 10.3390/ph15030270] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Paroli M, Caccavale R, Paroli MP, Spadea L, Accapezzato D. Janus Kinase Inhibitors: A New Tool for the Treatment of Axial Spondyloarthritis. Int J Mol Sci 2023;24. [PMID: 36674537 DOI: 10.3390/ijms24021027] [Reference Citation Analysis]
2 Zeidler H. [History of reactive arthritis. Historical milestones and future]. Z Rheumatol 2022. [PMID: 36006472 DOI: 10.1007/s00393-022-01253-x] [Reference Citation Analysis]
3 Lyu X, Chen J, Gao X, Yang J. Emerging story of gut dysbiosis in spondyloarthropathy: From gastrointestinal inflammation to spondyloarthritis. Front Cell Infect Microbiol 2022;12:973563. [DOI: 10.3389/fcimb.2022.973563] [Reference Citation Analysis]